Evidence map›Paper›PMID 20688901›Full record

ArticleAmerican journal of epidemiology2010

Invited commentary: The epicenter of translational science.

Robert A Hiatt

Abstract readComment
PubMed Publisher
In one paragraph

Article in American journal of epidemiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Mapping the evolving definitions of translational research.Journal of clinical and translational science · 2017
    Review
  5. Review
  6. Charting a future for epidemiologic training.Annals of epidemiology · 2015
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. The age gauge: older fathers having children.Cerebrum : the Dana forum on brain science
    Article
  12. Cancer and Dementia: It's Complicated.Alzheimer disease and associated disorders
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Robert A HiattDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California 94107, USA. rhiatt@cc.ucsf.edu
University of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiology is at the center of translational science. Uniquely among biomedical disciplines, the methods and perspective of epidemiology span research from discovery to effective interventions and ultimately to their dissemination and implementation. However, shorthand designations for various phases of translational science, such as "T1, T2, T3, and T4," may be proliferating past the level of their usefulness. It is worthwhile to reflect on the actual nature of the science undertaken by epidemiologists along the continuum of discovery to application. The new challenge for epidemiology is the integration of knowledge and effective interventions into various societal settings working with allied disciplines not necessarily in the biomedical domain to ensure that these interventions have their intended effects on individual and public health.

Indexed as

Diffusion of InnovationEpidemiologyGenomicsHumansPublic HealthTranslational Research, Biomedical

Identifiers

PMID20688901
OpenAlexW2128354951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.